287 related articles for article (PubMed ID: 17561826)
1. Striatal dopaminergic activity (FDOPA-PET) associated with cognitive items of a depression scale (MADRS) in Parkinson's disease.
Koerts J; Leenders KL; Koning M; Portman AT; van Beilen M
Eur J Neurosci; 2007 May; 25(10):3132-6. PubMed ID: 17561826
[TBL] [Abstract][Full Text] [Related]
2. Complementary positron emission tomographic studies of the striatal dopaminergic system in Parkinson's disease.
Antonini A; Vontobel P; Psylla M; Günther I; Maguire PR; Missimer J; Leenders KL
Arch Neurol; 1995 Dec; 52(12):1183-90. PubMed ID: 7492293
[TBL] [Abstract][Full Text] [Related]
3. Lack of association between dopamine transporter loss and non-motor symptoms in patients with Parkinson's disease: a detailed PET analysis of 12 striatal subregions.
Park SB; Kwon KY; Lee JY; Im K; Sunwoo JS; Lee KB; Roh H; Ahn MY; Park S; Kim SJ; Oh JS; Kim JS
Neurol Sci; 2019 Feb; 40(2):311-317. PubMed ID: 30415448
[TBL] [Abstract][Full Text] [Related]
4. Striatal dopamine transporter imaging correlates with depressive symptoms and tower of London task performance in Parkinson's disease.
Rektorova I; Srovnalova H; Kubikova R; Prasek J
Mov Disord; 2008 Aug; 23(11):1580-7. PubMed ID: 18618663
[TBL] [Abstract][Full Text] [Related]
5. [(18)F]FDOPA and [(18)F]CFT are both sensitive PET markers to detect presynaptic dopaminergic hypofunction in early Parkinson's disease.
Rinne OJ; Nurmi E; Ruottinen HM; Bergman J; Eskola O; Solin O
Synapse; 2001 Jun; 40(3):193-200. PubMed ID: 11304757
[TBL] [Abstract][Full Text] [Related]
6. Impaired cognitive performance in Parkinson's disease is related to caudate dopaminergic hypofunction and hippocampal atrophy.
Jokinen P; Brück A; Aalto S; Forsback S; Parkkola R; Rinne JO
Parkinsonism Relat Disord; 2009 Feb; 15(2):88-93. PubMed ID: 18434233
[TBL] [Abstract][Full Text] [Related]
7. Depressive symptoms in Parkinson's disease are related to reduced [123I]FP-CIT binding in the caudate nucleus.
Vriend C; Raijmakers P; Veltman DJ; van Dijk KD; van der Werf YD; Foncke EM; Smit JH; Berendse HW; van den Heuvel OA
J Neurol Neurosurg Psychiatry; 2014 Feb; 85(2):159-64. PubMed ID: 23813742
[TBL] [Abstract][Full Text] [Related]
8. The assessment of depression in Parkinson's disease.
Koerts J; Leenders KL; Koning M; Bouma A; van Beilen M
Eur J Neurol; 2008 May; 15(5):487-92. PubMed ID: 18355310
[TBL] [Abstract][Full Text] [Related]
9. Attenuation of fluctuating striatal synaptic dopamine levels in patients with Parkinson disease in response to subthalamic nucleus stimulation: a positron emission tomography study.
Nimura T; Yamaguchi K; Ando T; Shibuya S; Oikawa T; Nakagawa A; Shirane R; Itoh M; Tominaga T
J Neurosurg; 2005 Dec; 103(6):968-73. PubMed ID: 16381182
[TBL] [Abstract][Full Text] [Related]
10. Mesolimbic dopaminergic dysfunction in Parkinson's disease depression: evidence from a 123I-FP-CIT SPECT investigation.
Frosini D; Unti E; Guidoccio F; Del Gamba C; Puccini G; Volterrani D; Bonuccelli U; Ceravolo R
J Neural Transm (Vienna); 2015 Aug; 122(8):1143-7. PubMed ID: 25613061
[TBL] [Abstract][Full Text] [Related]
11. Cognitive slowing in Parkinson's disease is related to frontostriatal dopaminergic dysfunction.
Jokinen P; Karrasch M; Brück A; Johansson J; Bergman J; Rinne JO
J Neurol Sci; 2013 Jun; 329(1-2):23-8. PubMed ID: 23561982
[TBL] [Abstract][Full Text] [Related]
12. The relation of putamen and caudate nucleus 18F-Dopa uptake to motor and cognitive performances in Parkinson's disease.
Broussolle E; Dentresangle C; Landais P; Garcia-Larrea L; Pollak P; Croisile B; Hibert O; Bonnefoi F; Galy G; Froment JC; Comar D
J Neurol Sci; 1999 Jul; 166(2):141-51. PubMed ID: 10475108
[TBL] [Abstract][Full Text] [Related]
13. Hemispheric Network Expression in Parkinson's Disease: Relationship to Dopaminergic Asymmetries.
Tang CC; Holtbernd F; Ma Y; Spetsieris P; Oh A; Fink GR; Timmermann L; Eggers C; Eidelberg D
J Parkinsons Dis; 2020; 10(4):1737-1749. PubMed ID: 32925097
[TBL] [Abstract][Full Text] [Related]
14. Apathy and striatal dopamine defects in non-demented patients with Parkinson's disease.
Chung SJ; Lee JJ; Ham JH; Lee PH; Sohn YH
Parkinsonism Relat Disord; 2016 Feb; 23():62-5. PubMed ID: 26717857
[TBL] [Abstract][Full Text] [Related]
15. Pre- and post-synaptic dopamine imaging and its relation with frontostriatal cognitive function in Parkinson disease: PET studies with [11C]NNC 112 and [18F]FDOPA.
Cropley VL; Fujita M; Bara-Jimenez W; Brown AK; Zhang XY; Sangare J; Herscovitch P; Pike VW; Hallett M; Nathan PJ; Innis RB
Psychiatry Res; 2008 Jul; 163(2):171-82. PubMed ID: 18504119
[TBL] [Abstract][Full Text] [Related]
16. Regional striatal DOPA transport and decarboxylase activity in Parkinson's disease.
Kuwabara H; Cumming P; Yasuhara Y; Léger GC; Guttman M; Diksic M; Evans AC; Gjedde A
J Nucl Med; 1995 Jul; 36(7):1226-31. PubMed ID: 7790948
[TBL] [Abstract][Full Text] [Related]
17. "Depressed" caudate and ventral striatum dopamine transporter availability in de novo Depressed Parkinson's disease.
Yoo SW; Oh YS; Hwang EJ; Ryu DW; Lee KS; Lyoo CH; Kim JS
Neurobiol Dis; 2019 Dec; 132():104563. PubMed ID: 31377233
[TBL] [Abstract][Full Text] [Related]
18. Levodopa pharmacokinetic-pharmacodynamic modeling and 6-[18F]levodopa positron emission tomography in patients with Parkinson's disease.
Dietz M; Harder S; Graff J; Künig G; Vontobel P; Leenders KL; Baas H
Clin Pharmacol Ther; 2001 Jul; 70(1):33-41. PubMed ID: 11452242
[TBL] [Abstract][Full Text] [Related]
19. Apathy and striatal dopamine transporter levels in de-novo, untreated Parkinson's disease patients.
Santangelo G; Vitale C; Picillo M; Cuoco S; Moccia M; Pezzella D; Erro R; Longo K; Vicidomini C; Pellecchia MT; Amboni M; Brunetti A; Salvatore M; Barone P; Pappatà S
Parkinsonism Relat Disord; 2015 May; 21(5):489-93. PubMed ID: 25753457
[TBL] [Abstract][Full Text] [Related]
20. Cognitive impairment and the brain dopaminergic system in Parkinson disease: [18F]fluorodopa positron emission tomographic study.
Rinne JO; Portin R; Ruottinen H; Nurmi E; Bergman J; Haaparanta M; Solin O
Arch Neurol; 2000 Apr; 57(4):470-5. PubMed ID: 10768619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
